Best Mcl Podcasts (2025)

1
Knee MCL Repair with Internal Brace - #AMR361 18:11

13d ago18:11

18:11

Internal bracing is becoming a very popular procedure with orthopedic surgeons. Repairing ligaments and then augmenting the tissue with an internal brace has shown to be promising throughout the body, including the MCL of the knee. But, what do you do if there is prolonged stiffness? To see full show notes and more, head to: https://mikereinold.com…

1
Highlights from iwCAR-T 2025: improving the efficacy and safety of CAR T-cells & access in the community 23:38

1d ago23:38

23:38

Today's VJHemOnc podcast features discussions from the 7th International Workshop on CAR-T and bispecifics (iwCAR-T) 2025, which was held recently in Miami, FL. First you will hear from Elizabeth Budde, MD, PhD, City of Hope, Duarte, CA, Mohammad Rashidian, PhD, Dana-Farber Cancer Institute, Boston, MA, Michael Jain, MD, PhD, H. Lee Moffitt Cancer …

1
Updates to the ESMO CLL clinical practice guidelines and implications for relapsed therapy 19:49

13d ago19:49

19:49

This episode features leading experts Paolo Ghia, MD, Vita-Salute San Raffaele University, Milan, Italy, and Arnon Kater, MD, PhD, University of Amsterdam, Amsterdam, Netherlands, who provide key insights into the management of relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL), guided by the latest ESMO clinical practice recommendations.…

1
Highlights from iwMyeloma 2025: trial updates and practical considerations 35:15

19d ago35:15

35:15

VJHemOnc was delighted to be media partners for the 18th International Workshop on Multiple Myeloma (iwMyeloma), held in Miami, FL. This podcast episode features highlights from the meeting. First, you will hear from Rafael Fonseca, MD, Mayo Clinic, Phoenix, AZ, Ola Landgren, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL…

1
Updates to the ESMO CLL clinical practice guidelines: implications for frontline treatment 34:35

26d ago34:35

34:35

In this VJHemOnc podcast, experts Barbara Eichhorst, MD, University Hospital Cologne, Cologne, Germany, Lydia Scarfò, MD, Vita-Salute San Raffaele University and IRCCS San Raffaele Scientific Institute, Milan, Italy, and Anna Schuh, MD, PhD, University of Oxford, Oxford, UK, provide insights into the latest updates to the ESMO clinical practice gui…

1
Beyond The Spin - What Circular Fashion Gets Wrong (And What We’re Missing) 35:21

27d ago35:21

35:21

In this episode, host Philip Berman sits down with Dr Talia Hussain, whose recent academic paper on circular fashion sparked lively debate across the industry. Dr Hussain, a PhD in design innovation and MBA, is known for her critical analysis on the mainstream circular fashion narrative. Together, they take a deep dive into the promises—and potenti…

1
Oblique Injuries in Baseball Players - #AMR360 16:16

27d ago16:16

16:16

Oblique injuries are common in baseball players, and not so common in other sports. With baseball players training so much more in the offseason with high volume and max intent, it’s no wonder these injuries are rising. Here’s how we approach these injuries and how to progress them back to hitting. To see full show notes and more, head to: https://…

1
Elevating the standard of care in knee repair 37:16

28d ago37:16

37:16

Get expert perspectives on treating the entire knee from leading surgeons and the UFC Performance Institute’s Senior Director of Physical Therapy. With the aim of getting their patients back to their lives, the panel explains why they consider multiple aspects of knee preservation: ligament reconstruction (quad grafts, LET and multi-ligament), meni…

1
Highlights from EBMT 2025: preventing and managing GvHD, harnessing AI in transplant, & more 22:53

1M ago22:53

22:53

In this week’s VJHemOnc podcast, we’ll be sharing highlights from the 51st Annual Meeting of the EBMT, with a focus on the prevention and management of graft-versus-host disease (GvHD) and infections associated with stem cell transplantation (SCT). You will also hear about the potential of artificial intelligence (AI) in hematology and transplantat…

1
Sequencing therapies in R/R NHL: immunotherapy in DLBCL, BTKis in MCL, & more! 46:21

1M ago46:21

46:21

This podcast episode features experts Paolo Strati, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, Gloria Iacoboni, MD, PhD, Vall d’Hebron Institute of Oncology, Barcelona, Spain, and Manali Kamdar, MD, University of Colorado Cancer Center, Denver, CO, who discuss the sequencing of therapies in relapsed/refractory (R/R) non-Hod…

1
Restoring Range of Motion After Rotator Cuff Repair - #AMR359 14:21

1M ago14:21

14:21

Restoring range of motion after a rotator cuff repair is one of the most important factors in long-term patient satisfaction. Internal rotation is especially important, as a loss of IR can really limit their functional movements. There are many variables to consider when rehabbing a rotator cuff repair patient. Several factors will alter our speed …

1
Episode 1: Building Community Through Creativity with Dana Murray 38:33

1M ago38:33

38:33

In the premiere episode of Pillars of Progress, we sit down with Dana Murray — acclaimed musician, producer, and the visionary Founder and Executive Director of North Omaha Music and Arts (NOMA). Dana shares his journey from professional drummer to community leader, and how NOMA is using music, art, and education to empower youth, elevate talent, a…

1
Novel CAR strategies being explored in lymphoma: allogeneic products, trispecific CARs & new manufacturing platforms 18:06

2M ago18:06

18:06

CAR T-cell therapy has revolutionized the lymphoma treatment landscape in recent years. In this episode, we delve into cutting-edge CAR strategies being investigated for lymphoma, including allogeneic products, trispecific CARs, and more. Key highlights include insights into CTX112, a next-generation allogeneic CRISPR-Cas9 engineered CD19 CAR T-cel…

1
Approaches to optimizing induction therapy in AML: FLT3 inhibitors, menin inhibitors, CPX-351, & more! 23:26

2M ago23:26

23:26

Newly diagnosed acute myeloid leukemia (AML) is traditionally treated with intensive chemotherapy for eligible patients, but ongoing research is exploring the addition of targeted agents. This podcast focuses on approaches being explored to optimize induction therapy in AML, featuring experts Tapan Kadia, MD, The University of Texas MD Anderson Can…

1
Return to Running After ACL Surgery - #AMR358 20:08

2M ago20:08

20:08

Rehabilitation after ACL reconstruction is a long, sequential process. We look for specific criteria before progressing our athletes back to running. Here are the criteria we look for and the progression we follow for plyometrics, running, sprinting, and agility work to help athletes get back to competition after ACL surgery. To see full show notes…

1
Treating R/R mantle cell lymphoma: the role of BTK inhibitors, combination approaches being explored & overcoming resistance 16:52

2M ago16:52

16:52

BTK inhibitors have transformed the treatment landscape in both frontline and relapsed/refractory (R/R) mantle cell lymphoma (MCL), offering a targeted therapy option for patients. In this podcast, you will hear from Krish Patel, MD, Sarah Cannon Cancer Institute, Nashville, TN, Yucai Wang, MD, PhD, Mayo Clinic, Rochester, MN, Julie Vose, MD, Unive…

1
Beyond the Report: unpacking Lenzing's sustainability journey 37:54

2M ago37:54

37:54

In light of their 2024 Annual and Sustainability Report, Philip Berman catches up with Krishna Manda, Lenzing’s VP corporate sustainability, and Thomas Matiz, Lenzing’s global product sustainability lead, to chat about Lenzing's GHG emissions reporting, what is needed to achieve net-zero, and how Lenzing supports its customers and partners in achie…

1
California Dreamin' about new fashion laws with Maxine Bédat 23:32

2M ago23:32

23:32

Host Philip Berman talks to Maxine Bedat, Executive Director at New Standard Institute, the official sponsor of the Fashion Environmental Accountability Act, a new bill introduced into the California State Assembly at the start of February 2025 which, if enacted, would become the first law in the country to require brands to engage in “environmenta…

1
Addressing unmet needs in myeloma: early detection, frail/elderly patients, triple-class exposed disease, & more! 27:48

2M ago27:48

27:48

In recognition of Myeloma Awareness Month 2025, this podcast explores key unmet needs and unanswered questions in myeloma research and patient care, offering insights and strategies for healthcare professionals to address them. The discussion centers on four topics: the treatment of smoldering myeloma, managing frail and elderly patients, challenge…

1
Little League Elbow - #AMR357 20:19

2M ago20:19

20:19

Little League Elbow is a common injury in youth baseball players. Little League Elbow is a growth plate injury typically seen in baseball pitchers around the age of 13. At this age, the bone is typically the weak link, not the ligament. This is why we see more bony growth plate injuries than Tommy John injuries in youth athletes. These often take l…

1
What's the way to Net Zero? With the Apparel Impact Institute 30:25

2M ago30:25

30:25

What's the best way to Net Zero? In this episode of Ecotextile Talks, host Philip Berman explores the pathway to net zero in the textile industry with Pauline Op de Beeck, Climate Portfolio Director at the Apparel Impact Institute, and wet processing expert and Ecotextile News contributor Phil Patterson They discuss the newly released: "Low Carbon …

1
CAR T-cell therapy in ALL: trial updates, novel approaches, & real-world outcomes 18:39

3M ago18:39

18:39

CAR T-cell therapy has become an established treatment for several hematological malignancies, including acute lymphoblastic leukemia (ALL), and has significantly changed the therapeutic landscape for patients. In this podcast episode, renowned experts will share insight into the use of CAR-T in ALL, including updates of pivotal trials, novel appro…

1
Update on Sports PT Residencies - #AMR356 15:45

3M ago15:45

15:45

Over the last decade, the amount of sports physical therapy residency programs has skyrocketed. There are so many great programs now. Our students ask us all the time if they should do a residency. Our answer is always, “It depends.” They aren’t for everyone. Here are our current thoughts on sports PT residencies, who should consider them, and who …

1
Post-ASH amyloidosis highlights: the ANDROMEDA trial, risk stratification, value of MRD, & more! 13:15

3M ago13:15

13:15

Today's podcast features a discussion with experts Vaishali Sanchorawala, MD, Boston University School of Medicine, Boston, MA, and Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM, University College London Hospitals NHS Foundation Trust, London, UK, from the 66th ASH Annual Meeting and Exposition. They share their key highlights in amyloidosis fr…

1
Management of Patella Fractures (with Jan Szatkowski, MD) 42:23

3M ago42:23

42:23

On this episode, we have a comprehensive discussion on patella fractures with Dr. Jan Szatkowski, an orthopedic trauma surgeon at IU Health in Indianapolis, IN. He shares his extensive knowledge and experience in treating knee trauma, specifically patella fractures. Listen to gain insights into the various techniques for patella fracture management…

1
How big is fashion's plastic footprint? 37:47

3M ago37:47

37:47

Host Philip Berman discusses the findings of a groundbreaking 2024 study on the problem of plastic leakage in the textile industry with one of its co-authors Dr. Jesse Daystar, Cotton Incorporated's Vice President and Chief Sustainability Officer, and Dr. Patricia Holden, Bren School of Environmental Science and Management at the University of Cali…

1
Post-ASH non-malignant highlights: updates in sickle cell disease, thalassemia, and hemophilia 18:27

3M ago18:27

18:27

This episode of the VJHemOnc podcast covers updates in non-malignant hematological diseases from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. You will hear the latest updates in sickle cell disease (SCD), thalassemia, and hemophilia from leading experts. First, Sophia Delicou, MD, H…

1
Evaluation and Treatment of Biceps Pain - #AMR355 13:01

3M ago13:01

13:01

Ah, the diagnosis of biceps tendonitis. We’ve all seen it so many times on script from doctors. Is all anterior shoulder pain coming from the biceps? How can you tell? How does this change your rehab? We’ll answer all this and more in this episode. To see full show notes and more, head to: https://mikereinold.com/evaluation-and-treatment-of-biceps-…

1
Storing the future: cotton's hidden climate benefits 28:47

3M ago28:47

28:47

Host Philip Berman explores the fascinating world of biogenic carbon storage in cotton garments with Dr. Richard Venditti, from North Carolina State University, Steve Pires from Cotton Incorporated, and Emily Graham from Carhartt. Together, they delve into the climate benefits of cotton and how it can play a crucial role in the textile industry's s…

1
Post-ASH myeloma highlights: key takeaways for community physicians & trials to look out for in 2025 18:29

3M ago18:29

18:29

This podcast brings you exclusive updates on multiple myeloma from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, held in San Diego, CA. In this episode, experts Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, Rahul Banerjee, MD, FACP, Fred Hutchinson Cancer Cen…

1
Fashion brands falling short on climate action 37:11

4M ago37:11

37:11

In this episode, host Philip Berman sits down with Michael Schragger, Founder & Executive Director of the Sustainable Fashion Academy, to discuss the fashion industry's complex journey towards sustainability. Fresh off the release of STICA’s Progress Report from the end of 2024, Schragger gives a unique insight into the successes and challenges Sca…

1
Post-ASH AML highlights: novel approaches to frontline therapy, advances with menin inhibitors, & managing FLT3-ITD+ AML 28:59

4M ago28:59

28:59

In this podcast, we bring you exclusive updates on acute myeloid leukemia (AML) from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. You will hear insights into novel approaches to frontline chemotherapy and BCL2 inhibition from experts Ioannis Mantzaris, MD, Montefiore Medical Center/…

1
What it Takes to Start a Cash Based PT Practice 27:18

4M ago27:18

27:18

It’s so awesome to see so many cash-based physical therapy businesses starting around the country. It’s really been an amazing experience for us at Champion to be out-of-network with health insurances for over 10 years. In this episode, we have some advice, pros, and cons for those looking to succeed with this model. To see full show notes and more…

1
Patients Place: Lateral Meniscus Tears 31:23

4M ago31:23

31:23

In this episode, we delve into the intricacies of lateral meniscus tears, a common knee injury. This informative session is designed for patients seeking clarity about their condition and treatment options. Dr. Benner discusses the typical symptoms that accompany lateral meniscus tears, including pain and possible locking of the knee. He explains t…

1
Post-ASH MPN highlights: key trial updates in MF, novel approaches being explored in R/R disease, & more! 22:21

4M ago22:21

22:21

This podcast episode covers key highlights in myeloproliferative neoplasms (MPNs) from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. First, you will hear key trial updates in myelofibrosis (MF) from Andrew Kuykendall, MD, Moffitt Cancer Center, Tampa, FL, Lucia Masarova, MD, The Univ…

1
Post-ASH NHL highlights: novel combinations in the frontline setting and advancements with immunotherapy in the R/R setting 31:20

4M ago31:20

31:20

Today's podcast showcases key updates in non-Hodgkin lymphoma (NHL) from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. First, you will hear from Gilles Salles, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, Catherine Diefenbach, MD, NYU Langone, New York, NY, and Jia …

1
Post-ASH MDS highlights: managing anemia in LR-MDS and novel approaches to treating HR-MDS 19:02

4M ago19:02

19:02

This podcast is the second episode in our series spotlighting key highlights from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego, CA. This episode focuses on updates in myelodysplastic syndromes (MDS). You will hear insights into managing anemia in lower-risk MDS (LR-MDS) from Sophie Park,…

1
ACL Reconstruction with Lateral Extra-Articular Tenodesis (LET) - #AMR353 16:19

4M ago16:19

16:19

We’re starting to see more and more ACL reconstruction procedures with an LET, or lateral extra-articular tenodesis. Especially in revisions and younger female athletes. In this episode we talk about the technique, how it changes the rehab progression, and some tips on what to watch out for. To see full show notes and more, head to: https://mikerei…

1
Chairperson's Perspective: Novel Treatments for Newly Diagnosed Ph+ CML-CP: Striking the Balance of Treatment With Patient Goals and QoL

4M ago

—

Host: Jorge E. Cortes, MD Although the first-generation tyrosine kinase inhibitors (TKIs) revolutionized the treatment of Ph+ CML-CP, the rate of resistance to these agents is high, and many patients require further treatment with second- and third-line therapy. The development of newer drugs with unique mechanisms that can overcome these resistanc…

1
Chairperson's Perspective: Novel Treatments for Newly Diagnosed Ph+ CML-CP: Striking the Balance of Treatment With Patient Goals and QoL

4M ago

—

CME credits: 0.25 Valid until: 14-01-2026 Claim your CME credit at https://axismeded.com/programs/cme/chairpersons-perspective-novel-treatments-for-newly-diagnosed-ph-cml-cp-striking-the-balance-of-treatment-with-patient-goals-and-qol/28646/ Although the first-generation tyrosine kinase inhibitors (TKIs) revolutionized the treatment of Ph+ CML-CP, …

1
Post-ASH CLL highlights: BTK inhibitors & degraders, bispecific antibodies, & more! 16:31

4M ago16:31

16:31

VJHemOnc recently attended the 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, CA, where we gained expert insights into cutting-edge research in hematological malignancies. This podcast series will cover highlights in a variety of disease areas. Today's episode focuses on chronic lymphocytic leukemia (CLL). You…

1
Patients Place: MCL Tears 34:08

4M ago34:08

34:08

Welcome to another engaging episode of Patient's Place, specifically designed to break down complex medical topics for patients and non-clinicians. This episode dives deep into the world of Medial Collateral Ligament (MCL) tears, focusing on common mechanisms, symptoms, and treatment options. Join the discussion as we explore how MCL injuries are s…

1
What Athletic Qualities Do We Test (and How)? - #AMR352 14:19

5M ago14:19

14:19

If you want to help your athletes maximize their potential, you need to have a system to assess athletic qualities. This is important to individualize programming and monitor progress. We follow a few steps in our system: 1. Identify the athletic qualities needed in a sport 2. Identify an assessment to measure this quality 3. Determine the technolo…

1
Patients Place: PCL Tears 30:46

5M ago30:46

30:46

In this episode of The Shelburne Center podcast, we dive deep into the world of PCL (Posterior Cruciate Ligament) tears, a lesser-known but significant knee injury. Dr. Benner guides us through the various aspects of PCL tear diagnosis, focusing on the unique injury mechanisms typically associated with these tears. We explore the signs and symptoms…

1
Advancing ALK Inhibition Into Early-Stage NSCLC: Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection

5M ago

—

CME credits: 0.25 Valid until: 20-12-2025 Claim your CME credit at https://axismeded.com/programs/cme/advancing-alk-inhibition-into-early-stage-nsclc-integrating-biomarker-driven-therapies-to-reduce-recurrence-risk-post-resection/27056/ This animated podcast explores the evolving role of ALK inhibitors in managing early-stage non-small cell lung ca…

1
Advancing ALK Inhibition Into Early-Stage NSCLC: Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection

5M ago

—

Host: Mark Socinski, MD This animated podcast explores the evolving role of ALK inhibitors in managing early-stage non-small cell lung cancer (NSCLC). Dr. Mark Socinski discusses molecular profiling as a cornerstone for identifying ALK fusion–positive cases and highlights clinical data from pivotal trials. He also addresses the challenges of treatm…

1
Building Return to Sport Programs - #AMR351 24:01

5M ago24:01

24:01

One of the most common questions we tend to get over time is how to return athletes back to sport after an injury. This is one of the main topics in our online Champion Sports PT Mentorship, and probably the most popular portion of the program for past students (BTW, our next cohort starts in January… click here to learn more). In this episode, we …

1
What a waste! European textile reuse and recycling on brink of collapse 24:38

5M ago24:38

24:38

Our host Philip Berman sits down with Marie-Jeanne Gaertner, project and policy officer at RREUSE (Reuse and Recycling European Union Social Enterprises) to find out why the textile reuse and recycling sector in the European Union is facing an unprecedented crisis. Gaertner says that a recent open letter to the European Commission and member states…

1
Advancing treatment for BPDCN: current therapies, a deep dive into tagraxofusp, & emerging novel agents 28:52

5M ago28:52

28:52

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy characterized by involvement of the skin, bone marrow, and lymph nodes, often associated with a poor prognosis. In this podcast episode, Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, provides an in-depth explo…

1
Improving care for patients with SCD: pain management, ongoing projects & unmet needs 16:45

6M ago16:45

16:45

This week's podcast focuses on strategies to improve care for patients with sickle cell disease (SCD), featuring expert insights from the 19th Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT 2024), which was held in London, UK. You will hear from Natasha Archer, MD, MPH, Harvard Medical School, Boston, MA, Subarna Chakravorty, MB…

Podcasts Worth a Listen

Mcl Podcasts

Podcasts Worth a Listen